regulatory
confidence high
sentiment negative
materiality 0.65
Vivakor, Inc. (VIVK): Nasdaq/NYSE listing notice — Vivakor director resignation triggers Nasdaq independence non-compliance; cure period to June 2024
Vivakor, Inc.
- David Natan resigned from Board and all committee positions effective December 6, 2023.
- Board now lacks a majority of independent directors; Audit Committee has only two independent members.
- Nasdaq granted cure period until June 3, 2024 to regain compliance with Listing Rules 5605(b)(1) and 5605(c)(2)(A).
- No immediate effect on listing of common stock on Nasdaq Capital Market.
- Resignation was not due to any dispute with the Company or Board.